Search company, investor...

Predict your next investment

SOFTWARE (NON-INTERNET/MOBILE) | Healthcare Software
linkmed.com

Investments

5

About Linkmed

Linkmed specializes in providing Health Level Seven (HL7) integration tools and solutions to the healthcare industry.

Headquarters Location

1208B VFW Parkway Suite 203

Boston, Massachusetts, 02132,

United States

617- 676- 6165

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest Linkmed News

LinkMed to Provide First At-Home Fertility Monitoring in U.S.

Oct 20, 2022

. News Provided By Share This Article Landmark Announcement to be Made at 2022 Reproductive Medicine Congress We are helping revolutionize fertility and early pregnancy care by applying highly advanced, cost-effective mobile imaging technology.” — Liteng Xu, LinkMed CEO LOS ANGELES, CA, UNITED STATES, October 20, 2022 / EINPresswire.com / -- For the first time, women in the United States will have access to at-home and at-work medical monitoring for fertility and early pregnancy, thanks to the groundbreaking formation of a medical start-up company – LinkMed . Representatives of Link Mobile Medical Solution, Inc. (LinkMed) to make the landmark announcement during the October 2022 Scientific Congress of the American Society for Reproductive Medicine (ASRM) in Anaheim, California. The new company, known as LinkMed ( https://www.linkmed-inc.com ), becomes the nation’s first to offer remote medical imaging for monitoring a woman’s fertility and early-pregnancy status – services never before available in the American reproductive medicine landscape. The company will perform sonograms and blood draws from the comfort of patients’ own homes or from other settings – like at-work offices – convenient to patients. “We are helping revolutionize fertility and early pregnancy care by applying highly advanced, cost-effective mobile imaging technology to give clinicians information more dependable than that obtained from traditional methods and systems,” says LinkMed CEO Liteng Xu. “Our mobile technology creates sharper, higher quality scans with greater diagnostic value.” The LinkMed software platform also serves as a basis for the development of a new, powerful app connecting fertility and pregnancy patients with clinical providers, much as Uber connects its drivers with riders, Xu stated. “Physicians are able to use the platform to make notes on imaging results and alert patients. Patients, too, can access the software to comment on findings and query their providers.” As an at-home diagnostic provider, LinkMed employs skilled phlebotomists and accredited, registered diagnostic medical sonographers who specialize in fertility and pregnancy assessment in remote locations. Patients have the option of making appointments online, by phone, or by email. After the scanning is performed, the platform sends results via email to both patients and their doctors and stores the information in a secure LinkMed portal, readily accessible to patients. The company is entering a global fertility market where demand in general for convenient, portable, and remote medical technology and services is growing exponentially. A recent industry report from Mordor Intelligence attributes this demand as one reason for the mobile imaging market’s forecasted annual compound growth rate of 5.1 percent between now and 2027. Earlier this year (2022), growth strategy consulting firm Frost & Sullivan indicated mobile medical systems offer “rapid, accurate, and effective diagnosis…with the ability to improve patients’ health outcomes.” Other experts cite the safety and flexibility in scheduling of mobile imaging technology. LinkMed’s entry into the mobile imaging market taps an unmet need among U.S. patients requiring fertility and pregnancy monitoring, Xu said. The company currently offers four major areas of service: • Assessment of patients who desire to know their current fertility status. Such information is particularly useful for potential egg donors, cancer patients, and those considering the possibility of invitro fertilization (IVF). • In-cycle IVF monitoring because IVF patients, including surrogates, must undergo regular monitoring for the duration of their cycle. • Post-operative evaluation of patients who have undergone a fertilization procedure, such as egg retrieval or transfer. • Monitoring of early pregnancies – up to 14 weeks gestation. • Because proper fertility monitoring involves both scanning and blood assessment, LinkMed offers same-day, at-home blood draws and testing. The blood is evaluated for hormone levels to ensure the best chances of a successful pregnancy. Although LinkMed now serves only California and bordering cities in Nevada, representatives indicate the company is positioned to grow rapidly to other parts of the country, beginning in 2023. Link Mobile Medical Solution, Inc., doing business as LinkMed, is the first provider of at-home mobile medical imaging for fertility and early pregnancy patients in the U.S. Although LinkMed pregnancy monitoring currently ends at 14 weeks, gestation, the company plans eventually to expand its services to address all obstetrics and gynecology needs. https://www.linkmed-inc.com Geoffrey Hawes

Linkmed Investments

5 Investments

Linkmed has made 5 investments. Their latest investment was in AnaMar Medical as part of their Other Investors on .

CBI Logo

Linkmed Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

Other Investors

AnaMar Medical

Yes

Other Investors

Subscribe to see more

Subscribe to see more

0

Other Investors

Subscribe to see more

Subscribe to see more

0

Other Investors

Subscribe to see more

Subscribe to see more

0

Other Investors

Subscribe to see more

Subscribe to see more

0

Date

Round

Other Investors

Other Investors

Other Investors

Other Investors

Other Investors

Company

AnaMar Medical

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

0

0

0

0

Linkmed Team

1 Team Member

Linkmed has 1 team member, including former Chief Operating Officer, Agneta Edberg.

Name

Work History

Title

Status

Agneta Edberg

Viatris, Recopharma, Bactiguard, Pfizer, Pharmacia Corporation, Pharmacia & Upjohn, Orion, and Orion Corporation

Chief Operating Officer

Former

Name

Agneta Edberg

Work History

Viatris, Recopharma, Bactiguard, Pfizer, Pharmacia Corporation, Pharmacia & Upjohn, Orion, and Orion Corporation

Title

Chief Operating Officer

Status

Former

Compare Linkmed to Competitors

Caristix Logo
Caristix

Caristix is a company that focuses on healthcare IT, specifically in the domain of data flow and interoperability for hospitals and other healthcare partners. The company offers software solutions that automate tasks related to interoperability and data flow, such as scoping, testing, and maintenance, with the aim of simplifying the integration of complex IT systems in healthcare settings. The primary sectors that Caristix serves are the healthcare and IT industries. It is based in Quebec City, Quebec.

iNTERFACEWARE Logo
iNTERFACEWARE

iNTERFACEWARE specializes in healthcare data integration, providing solutions within the healthcare technology sector. The company offers the Iguana Integration Engine, a platform designed to connect electronic medical records (EMRs), electronic health records (EHRs), and various healthcare systems, devices, and applications, facilitating the exchange of healthcare data in multiple formats and protocols. iNTERFACEWARE primarily serves the healthcare industry, offering integration services, training, and resources to healthcare providers and software companies. It is based in Toronto, Ontario.

E
Eversolve

Eversolve specializes in application integration within the healthcare sector, focusing on interoperability and standard-based solutions. The company offers tools, services, and expertise to enable healthcare vendors and providers to integrate their applications and devices, ensuring efficient data exchange and communication. Eversolve primarily serves healthcare vendors, providers, and government agencies seeking to implement Electronic Health Record Systems and Personal Electronic Health Records. It is based in New Hampshire, United States.

Commure Logo
Commure

Commure provides a healthcare technology platform. It helps to boost its users' clinical and financial performance with applications designed to streamline care delivery ensuring revenue integrity and also keep its users' workforce safe from violence with a discreet badge designed to call for help. Commure was formerly known as PatientKeeper. The company was founded in 2017 and is based in San Francisco, California.

Graphite Health Logo
Graphite Health

Graphite Health is a software company that focuses on creating a comprehensive digital ecosystem for the seamless exchange of health data, operating within the healthcare and technology sectors. The company's main services include the development and deployment of applications to healthcare systems, and providing a marketplace for building applications into participating healthcare systems. Graphite Health primarily sells to the healthcare industry. It was founded in 2019 and is based in Utah, United States.

Zus Health Logo
Zus Health

Zus Health specializes in healthcare data interoperability. The company offers a shared health data platform that provides patient data at the point of care through application program interface (API), embedded components, and direct electronic health records (EHR) integrations. The platform is primarily used by healthcare organizations to understand patient history, streamline intake processes, and monitor patient medication adherence. It was formerly known as Zeus Healthcare Technologies. It was founded in 2020 and is based in Boston, Massachusetts.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.